Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ... Cell 161 (5), 1164-1174, 2015 | 471 | 2015 |
A synthetic biology framework for programming eukaryotic transcription functions AS Khalil, TK Lu, CJ Bashor, CL Ramirez, NC Pyenson, JK Joung, ... Cell 150 (3), 647-658, 2012 | 396 | 2012 |
Broad targeting specificity during bacterial type III CRISPR-Cas immunity constrains viral escape NC Pyenson, K Gayvert, A Varble, O Elemento, LA Marraffini Cell host & microbe 22 (3), 343-353. e3, 2017 | 135 | 2017 |
Creating single-copy genetic circuits JW Lee, A Gyorgy, DE Cameron, N Pyenson, KR Choi, JC Way, PA Silver, ... Molecular cell 63 (2), 329-336, 2016 | 77 | 2016 |
Type III CRISPR-Cas systems: when DNA cleavage just isn’t enough NC Pyenson, LA Marraffini Current opinion in microbiology 37, 150-154, 2017 | 58 | 2017 |
Co-evolution within structured bacterial communities results in multiple expansion of CRISPR loci and enhanced immunity NC Pyenson, LA Marraffini Elife 9, e53078, 2020 | 32 | 2020 |
Community ecology of phages on a clonal bacterial host NC Pyenson, A Leeks, O Nweke, J Goldford, P Turner, KR Foster, ... bioRxiv, 2023.09. 01.555216, 2023 | 1 | 2023 |
Expansion of CRISPR loci with multiple memories of infection enables the survival of structured bacterial communities NC Pyenson, LA Marraffini bioRxiv, 747212, 2019 | 1 | 2019 |
Predictive microbial community changes across a temperature gradient X Sun, J Folmar, A Favier, N Pyenson, A Sanchez, M Rebolleda-Gomez bioRxiv, 2023.07. 28.550899, 2023 | | 2023 |
O1-04-08 C. ELEGANS MODELS OF ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE: SYSTEMS BIOLOGY IDENTIFIES AN INTERACTION BETWEEN TAU AND LRRK2 B Wolozin, M Guillily, A Ferree, H Li, N Pyenson, K Smith, S Saha, ... Alzheimer's & Dementia 6, S78-S78, 2010 | | 2010 |
Current Subject Limits AS Khalil, TK Lu, CJ Bashor, CL Ramirez, NC Pyenson, JK Joung, ... Cell 150, 3, 0 | | |